Retrieve available abstracts of 89 articles: HTML format
Single Articles
April 2025
MOORE LW, Brombosz EW, Ghobrial RM To Sleeve or Not to Sleeve: Validation of Liver Transplantation with Sleeve
Gastrectomy.
J Hepatol. 2025 Apr 15:S0168-8278(25)00242-9. doi: 10.1016/j.jhep.2025. PubMed
BURKE L, Bernal W, Pirani T, Agarwal B, et al Plasma exchange does not improve overall survival in patients with acute liver
failure in a real-world cohort.
J Hepatol. 2025;82:615-621. PubMedAbstract available
March 2025
HUWYLER F, Pfister M, Binz J, Tibbitt MW, et al Benefits of multi-day ex situ perfusion include dampened ischemia reperfusion
injury in liver transplantation.
J Hepatol. 2025 Mar 25:S0168-8278(25)00208-9. doi: 10.1016/j.jhep.2025. PubMed
LARSON EL, Ellias SD, Blezek DJ, Klug J, et al Simultaneous liver transplant and sleeve gastrectomy provides durable weight
loss, improves metabolic syndrome and reduces allograft steatosis.
J Hepatol. 2025 Mar 13:S0168-8278(25)00139-4. doi: 10.1016/j.jhep.2025. PubMedAbstract available
ARTRU F, Ursic-Bedoya J, L'Hermite S, Saliba F, et al Reply to : "Long-term outcome following liver transplantation of patients with
ACLF grade 3 : Need of redefining boundaries ?".
J Hepatol. 2025 Mar 5:S0168-8278(25)00133-3. doi: 10.1016/j.jhep.2025. PubMed
EDEN J, Thorne AM, Bodewes SB, Patrono D, et al Assessment of liver graft quality during hypothermic oxygenated perfusion: The
first international validation study.
J Hepatol. 2025;82:523-534. PubMedAbstract available
February 2025
HE K, Chen L, Xia Q Is MELD-Cr an Accurate Predictor of Liver Transplant Outcomes? A Call for
Refinement in Allocation Criteria.
J Hepatol. 2025 Feb 20:S0168-8278(25)00095-9. doi: 10.1016/j.jhep.2025. PubMed
ROSENSTENGLE C, Serper M, Asrani SK, Bittermann T, et al Variation in intention-to-treat survival by MELD subtypes: All models created for
end-stage liver disease are not equal.
J Hepatol. 2025;82:268-276. PubMedAbstract available
January 2025
MISHRA AK Long-term outcome following liver transplantation of patients with ACLF grade 3 :
Need of redefining boundaries?
J Hepatol. 2025 Jan 23:S0168-8278(25)00024-8. doi: 10.1016/j.jhep.2025. PubMed
ACEITUNO L, Gravely AK, O'Kane GM, Vogel A, et al The use of immunotherapy pre-liver transplant.
J Hepatol. 2025 Jan 3:S0168-8278(24)02702-8. doi: 10.1016/j.jhep.2024. PubMed
REZAEE-ZAVAREH MS, Yeo YH, Wang T, Guo Z, et al Impact of pre-transplant immune checkpoint inhibitor use on post-transplant
outcomes in HCC: A systematic review and individual patient data meta-analysis.
J Hepatol. 2025;82:107-119. PubMedAbstract available
EDEN J, Bruggenwirth IMA, Berlakovich G, Buchholz BM, et al Long-term outcomes after hypothermic oxygenated machine perfusion and
transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study).
J Hepatol. 2025;82:97-106. PubMedAbstract available
December 2024
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma.
J Hepatol. 2024 Dec 16:S0168-8278(24)02508-X. doi: 10.1016/j.jhep.2024. PubMedAbstract available
November 2024
DE GOEIJ FHC, Wehrle CJ, Abassi F, Satish S, et al Mastering the Narrative: Precision Reporting of Risk and Outcomes in Liver
Transplantation.
J Hepatol. 2024 Nov 16:S0168-8278(24)02713-2. doi: 10.1016/j.jhep.2024. PubMedAbstract available
October 2024
SAMUEL D EASL Clinical Practice Guidelines on liver transplantation.
J Hepatol. 2024 Oct 23:S0168-8278(24)02440-1. doi: 10.1016/j.jhep.2024. PubMedAbstract available
PARENTE A, Wehrle CJ, Schold JD, Panconesi R, et al Reply to: "Trends in current use of machine perfusion for donation after cardiac
death donors in the US".
J Hepatol. 2024;81:e189-e191. PubMed
MATEVISH LE, Vagefi PA, Patel MS Trends in current use of machine perfusion for donation after cardiac death
donors in the US.
J Hepatol. 2024;81:e187-e188. PubMed
September 2024
REZAEE-ZAVAREH MS, Guo Z, Yang JD Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors
for Hepatocellular Carcinoma: A Response to Recent Commentaries.
J Hepatol. 2024 Sep 19:S0168-8278(24)02558-3. doi: 10.1016/j.jhep.2024. PubMed
TABRIZIAN P, Holzner M, Ajmera V, Kim AK, et al Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving
immunotherapy before liver transplant: the multicenter VITALITY study.
J Hepatol. 2024 Sep 8:S0168-8278(24)02541-8. doi: 10.1016/j.jhep.2024. PubMedAbstract available
ALLEN E, Taylor R, Gimson A, Thorburn D, et al Transplant benefit-based offering of deceased donor livers in the United Kingdom.
J Hepatol. 2024;81:471-478. PubMedAbstract available
August 2024
MAGAZ M, Giudicelli-Lett H, G Abraldes J, Nicoara-Farcau O, et al Porto-sinusoidal vascular liver disorder with portal hypertension: Natural
History and Long-Term Outcome.
J Hepatol. 2024 Aug 22:S0168-8278(24)02481-4. doi: 10.1016/j.jhep.2024. PubMedAbstract available
DE HAAN J, Termorshuizen F, de Keizer N, Gommers D, et al One-year transplant-free survival following hospital discharge after ICU
admission for ACLF in the Netherlands.
J Hepatol. 2024;81:238-247. PubMedAbstract available
July 2024
VAN LEEUWEN LL, Irizar H, Kim-Schluger L, Florman S, et al The Potential of Machine Learning to Predict Early Allograft Dysfunction after
Normothermic Machine Perfusion in Liver transplantation.
J Hepatol. 2024 Jul 31:S0168-8278(24)02438-3. doi: 10.1016/j.jhep.2024. PubMed
HAO L, Shan D, Xue J Strategic Timing and Patient Selection for ICIs Prior to Liver Transplantation
for HCC.
J Hepatol. 2024 Jul 27:S0168-8278(24)02432-2. doi: 10.1016/j.jhep.2024. PubMed
ARTRU F, Sacleux SC, Ursic-Bedoya J, Ntandja Wandji LC, et al Long-term outcome following liver transplantation of patients with ACLF grade 3.
J Hepatol. 2024 Jul 7:S0168-8278(24)02346-8. doi: 10.1016/j.jhep.2024. PubMedAbstract available
June 2024
FUSTER-ANGLADA C, Mauro E, Ferrer-Fabrega J, Caballol B, et al Histological predictors of aggressive recurrence of hepatocellular carcinoma
after liver resection.
J Hepatol. 2024 Jun 24:S0168-8278(24)02324-9. doi: 10.1016/j.jhep.2024. PubMedAbstract available
ESSER H, Kilpatrick AM, Man TY, Aird R, et al Primary cilia as a targetable node between biliary injury, senescence and
regeneration in liver transplantation.
J Hepatol. 2024 Jun 13:S0168-8278(24)02302-X. doi: 10.1016/j.jhep.2024. PubMedAbstract available
HE T, Sun K, Zou J Biomarker predictors and LRT strategies for HCC recurrence post-liver
transplantation: A comment.
J Hepatol. 2024 Jun 6:S0168-8278(24)00422-7. doi: 10.1016/j.jhep.2024. PubMed
LI M, Bhoori S, Mehta N, Mazzaferro V, et al Immunotherapy for hepatocellular carcinoma: the next evolution in expanding
access to liver transplantation.
J Hepatol. 2024 Jun 5:S0168-8278(24)00423-9. doi: 10.1016/j.jhep.2024. PubMedAbstract available
NORMAN JS, Mehta N Reply to: "Enhancing HCC recurrence prediction after liver transplantation: From
DCP plus AFP-L3 model to GALAD score".
J Hepatol. 2024;80:e273-e274. PubMed
May 2024
CHICHELNITSKIY E, Goldschmidt I, Ruhl L, Rubsamen N, et al Plasma immune signatures can predict rejection-free survival in the first year
after pediatric liver transplantation.
J Hepatol. 2024 May 29:S0168-8278(24)00367-2. doi: 10.1016/j.jhep.2024. PubMedAbstract available
MONTANO-LOZA AJ, Lytvyak E, Hirschfield G, Hansen BE, et al Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss
and Mortality in Recurrent Primary Biliary Cholangitis after Liver
Transplantation.
J Hepatol. 2024 May 29:S0168-8278(24)00345-3. doi: 10.1016/j.jhep.2024. PubMedAbstract available
SPADA M, Angelico R, Trapani S, Masiero L, et al Reply to: "Tailoring allocation policies and improving access to pediatric liver
transplantation in Italy: outframing and concluding".
J Hepatol. 2024 May 15:S0168-8278(24)00346-5. doi: 10.1016/j.jhep.2024. PubMed
GAMBELLA A, Salvi M, Molinari F Response to: Application of Digital Pathology in Liver Transplantation.
J Hepatol. 2024 May 15:S0168-8278(24)00350-7. doi: 10.1016/j.jhep.2024. PubMed
MULLER X, Rossignol G, Boulanger N, Mohkam K, et al In situ or ex situ split: Does it all come down to static cold storage?
J Hepatol. 2024;80:e210-e211. PubMed
March 2024
LI Y, Yang F, Liu K Application of Digital Pathology in Liver Transplantation.
J Hepatol. 2024 Mar 23:S0168-8278(24)00207-1. doi: 10.1016/j.jhep.2024. PubMed
LAMARQUE C, Segaux L, Bachellier P, Buchard B, et al Evaluation of a delayed liver transplantation strategy for patients with HCC
receiving bridging therapy: the DELTA-HCC study.
J Hepatol. 2024 Mar 21:S0168-8278(24)00202-2. doi: 10.1016/j.jhep.2024. PubMedAbstract available
GAMBELLA A, Salvi M, Molinaro L, Patrono D, et al Improved assessment of donor liver steatosis using Banff consensus
recommendations and deep learning algorithms.
J Hepatol. 2024;80:495-504. PubMedAbstract available
February 2024
MARTIN-MATEOS R, Martinez-Arenas L, Carvalho-Gomes A, Aceituno L, et al Multidrug-resistant bacterial infections after liver transplantation: prevalence,
impact, and risk factors.
J Hepatol. 2024 Feb 28:S0168-8278(24)00128-4. doi: 10.1016/j.jhep.2024. PubMedAbstract available
DE VILLE DE GOYET J Tailoring allocation policies and improving access to pediatric liver
transplantation in Italy: outframing and concluding: Comment on:Tailoring
allocation policies and improving access to pediatric liver transplantation over
a 16-year period. Spada M,
J Hepatol. 2024 Feb 12:S0168-8278(24)00126-0. doi: 10.1016/j.jhep.2024. PubMed
SOIN A, Lesurtel M, Clavien PA To the editor: Reply to the letter by Liu et al. entitled "Patients with
Hepatocellular carcinoma and portal vein tumour thrombosis after successful
downstaging may be candidates for liver transplantation: A meta-analysis".
J Hepatol. 2024 Feb 8:S0168-8278(24)00101-6. doi: 10.1016/j.jhep.2024. PubMed
January 2024
LAUTERIO A, Cillo U, De Carlis R, Bernasconi D, et al Reply to: "Outcome of in-situ split liver transplantation in Italy over the last
25 years: an alternative analysis and personal view".
J Hepatol. 2024 Jan 25:S0168-8278(24)00057-6. doi: 10.1016/j.jhep.2024. PubMed
TABRIZIAN P, Abdelrahim M, Schwartz M Immunotherapy and Transplantation for Hepatocellular Carcinoma.
J Hepatol. 2024 Jan 20:S0168-8278(24)00053-9. doi: 10.1016/j.jhep.2024. PubMed
December 2023
NORMAN JS, Mehta N Reply to: Incorporating AFP-L3 and DCP in selecting patients with hepatocellular
carcinoma for liver transplantation: what are the optimal criteria?
J Hepatol. 2023 Dec 26:S0168-8278(23)05371-0. doi: 10.1016/j.jhep.2023. PubMed
SPADA M, Angelico R, Trapani S, Masiero L, et al Tailoring allocation policies and improving access to pediatric liver
transplantation over a 16-year period.
J Hepatol. 2023 Dec 18:S0168-8278(23)05308-4. doi: 10.1016/j.jhep.2023. PubMedAbstract available
SMEETS JJH, van Malenstein H, van der Merwe S, Nevens F, et al SARS-CoV-2 anti-spike IgG antibodies are present in all liver transplant
recipients after fifth vaccine dose.
J Hepatol. 2023 Dec 16:S0168-8278(23)05362-X. doi: 10.1016/j.jhep.2023. PubMed
PARENTE A, Jiao C, Eden J, Dutkowski P, et al machine perfusion, randomized controlled trials, liver transplantation, immune
cellsPerfusate immune cell profiling during machine perfusion - A new tool to
link risk and immune response after liver transplantation?
J Hepatol. 2023 Dec 16:S0168-8278(23)05364-3. doi: 10.1016/j.jhep.2023. PubMed
HAHN M, Herber A, Berg T, Seehofer D, et al Enhancing HCC Recurrence Prediction after Liver Transplantation: from DCP plus
AFP-L3 model to GALAD Score.
J Hepatol. 2023 Dec 16:S0168-8278(23)05357-6. doi: 10.1016/j.jhep.2023. PubMed
DE CARLIS R, Lauterio A, Bernasconi D, Taner B, et al Reply to: "Excellent long-term outcomes after sequential hypothermic and
normothermic machine perfusion challenges the importance of functional donor warm
ischemia time in DCD liver transplantation": Further comments on the changing
role of donor warm
J Hepatol. 2023;79:e245-e247. PubMed
November 2023
PARENTE A, Dondossola D, Dutkowski P, Schlegel A, et al Current evidence on the beneficial HOPE-effect based on systematic reviews and
meta-analyses in liver transplantation.
J Hepatol. 2023 Nov 10:S0168-8278(23)05233-9. doi: 10.1016/j.jhep.2023. PubMed
LIU J, Qian J, Yang Z, Zhou L, et al Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after
successful downstaging may be candidates for liver transplantation:A
meta-analysis.
J Hepatol. 2023 Nov 6:S0168-8278(23)05231-5. doi: 10.1016/j.jhep.2023. PubMed
October 2023
MURRAY SM, Pose E, Wittner M, Londono MC, et al Immune responses and clinical outcomes after COVID-19 vaccination in patients
with liver disease and in liver transplant recipients.
J Hepatol. 2023 Oct 18:S0168-8278(23)05174-7. doi: 10.1016/j.jhep.2023. PubMedAbstract available
DE VILLE DE GOYET J Outcome of in-situ split liver transplantation in Italy over the last 25 years :
an alternative analysis and personal view.
J Hepatol. 2023 Oct 12:S0168-8278(23)05151-6. doi: 10.1016/j.jhep.2023. PubMed
SHA M, Cao J, Xia Q Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma
for liver transplantation: what are the optimal criteria?
J Hepatol. 2023 Oct 9:S0168-8278(23)05162-0. doi: 10.1016/j.jhep.2023. PubMed
September 2023
ABERG F, Sallinen V, Tuominen S, Adam R, et al Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing
cholangitis - a propensity-score matched intention-to-treat analysis.
J Hepatol. 2023 Sep 16:S0168-8278(23)05100-0. doi: 10.1016/j.jhep.2023. PubMedAbstract available
CHOUDHARY NS, Dhampalwar S, Saraf N, Soin AS, et al Metabolic dysfunction-associated steatotic liver disease: Where does
non-alcoholic fatty liver disease in liver transplant recipients fit in this new
definition?
J Hepatol. 2023 Sep 15:S0168-8278(23)05098-5. doi: 10.1016/j.jhep.2023. PubMed
NORMAN JS, Li PJ, Kotwani P, Shui AM, et al AFP-L3 and DCP Strongly Predict Early Hepatocellular Carcinoma Recurrence After
Liver Transplantation.
J Hepatol. 2023 Sep 6:S0168-8278(23)05074-2. doi: 10.1016/j.jhep.2023. PubMedAbstract available
HERNAEZ R, Karvellas CJ, Liu Y, Sacleux SC, et al The novel SALT-M score predicts 1-year post-transplant mortality in patients with
severe acute-on-chronic liver failure.
J Hepatol. 2023;79:717-727. PubMedAbstract available
EDEN J, Dutkowski P, Schlegel A Reply to: "How many liver grafts could be recovered after implementation of
donation after cardiac death in Germany?".
J Hepatol. 2023;79:e120-e121. PubMed
EDEN J, von Felten S, Dutkowski P, Schlegel A, et al Reply to: "A multicenter randomized-controlled trial of hypothermic oxygenated
perfusion (HOPE) for human liver grafts before transplantation".
J Hepatol. 2023;79:e116-e118. PubMed
SHARMA N, Pandey S, Yadav M, Mathew B, et al Biomolecular map of albumin identifies signatures of severity and early mortality
in acute liver failure.
J Hepatol. 2023;79:677-691. PubMedAbstract available
HAKEEM AR, Taylor R, Prasad R Comment on "Low utilization of adult-to-adult LDLT in Western countries despite
excellent outcomes: International multicentre analysis of the US, the UK, and
Canada".
J Hepatol. 2023;79:e112-e114. PubMed
CZIGANY Z, Michalski CW A multicenter randomized-controlled trial of hypothermic oxygenated perfusion
(HOPE) for human liver grafts before transplantation.
J Hepatol. 2023;79:e114-e116. PubMed
August 2023
TANG G, Zhang L, Zhou R Letter to the Editor: Machine perfusion techniques for liver transplantation - A
meta-analysis of the first seven randomized controlled trials.
J Hepatol. 2023 Aug 8:S0168-8278(23)05045-6. doi: 10.1016/j.jhep.2023. PubMed
EASL Clinical Practice Guidelines on acute-on-chronic liver failure.
J Hepatol. 2023;79:461-491. PubMedAbstract available
KARTOUN U Fairness metrics: Additional principles to consider for improving MELD.
J Hepatol. 2023;79:e80-e81. PubMed
July 2023
VAN LEEUWEN OB, Bodewes SB, Porte RJ, de Meijer VE, et al Excellent long-term outcome after sequential hypothermic and normothermic machine
perfusion challenges the importance of functional donor warm ischemia time in DCD
liver transplantation.
J Hepatol. 2023 Jul 27:S0168-8278(23)05004-3. doi: 10.1016/j.jhep.2023. PubMed
LAUTERIO A, Cillo U, Spada M, Trapani S, et al Improving outcomes of in situ split liver transplantation in Italy over the last
25 years.
J Hepatol. 2023 Jul 27:S0168-8278(23)04988-7. doi: 10.1016/j.jhep.2023. PubMedAbstract available
June 2023
BRAADLAND PR, Bergquist A, Kummen M, Bossen L, et al Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing
cholangitis before and after liver transplantation.
J Hepatol. 2023 Jun 14:S0168-8278(23)00415-4. doi: 10.1016/j.jhep.2023. PubMedAbstract available
LIM WH, Ng CH, Hao Tan DJ, Tseng M, et al Natural history of NASH cirrhosis in liver transplant waitlist registrants.
J Hepatol. 2023 Jun 10:S0168-8278(23)00412-9. doi: 10.1016/j.jhep.2023. PubMedAbstract available
PARENTE A, Tirotta F, Pini A, Eden J, et al Machine perfusion techniques for liver transplantation - A meta-analysis of the
first seven randomized controlled trials.
J Hepatol. 2023 Jun 9:S0168-8278(23)00399-9. doi: 10.1016/j.jhep.2023. PubMedAbstract available
KAPLAN A, Korenjak M, Brown RS Jr Post-liver transplantation patient experience.
J Hepatol. 2023;78:1234-1244. PubMedAbstract available
BHAT M, Rabindranath M, Chara BS, Simonetto DA, et al Artificial intelligence, machine learning, and deep learning in liver
transplantation.
J Hepatol. 2023;78:1216-1233. PubMedAbstract available
MONTANO-LOZA AJ, Rodriguez-Peralvarez ML, Pageaux GP, Sanchez-Fueyo A, et al Liver transplantation immunology: Immunosuppression, rejection, and
immunomodulation.
J Hepatol. 2023;78:1199-1215. PubMedAbstract available
DE CARLIS R, Paolo Muiesan, Taner B Donation after circulatory death: Novel strategies to improve the liver
transplant outcome.
J Hepatol. 2023;78:1169-1180. PubMedAbstract available
GERMANI G, Mathurin P, Lucey MR, Trotter J, et al Early liver transplantation for severe acute alcohol-related hepatitis after more
than a decade of experience.
J Hepatol. 2023;78:1130-1136. PubMedAbstract available
SOIN A, Lesurtel M, Bhangui P, Cocchi L, et al Are patients with hepatocellular carcinoma and portal vein tumour thrombosis
candidates for liver transplantation?
J Hepatol. 2023;78:1124-1129. PubMedAbstract available
ARTRU F, Goldberg D, Kamath PS Should patients with acute-on-chronic liver failure grade 3 receive higher
priority for liver transplantation?
J Hepatol. 2023;78:1118-1123. PubMedAbstract available
TANDON P, Zanetto A, Piano S, Heimbach JK, et al Liver transplantation in the patient with physical frailty.
J Hepatol. 2023;78:1105-1117. PubMedAbstract available
BURRA P The changing world of liver transplantation.
J Hepatol. 2023;78:1087-1088. PubMed
SCHLEGEL A, Mergental H, Fondevila C, Porte RJ, et al Machine perfusion of the liver and bioengineering.
J Hepatol. 2023;78:1181-1198. PubMedAbstract available
TANER T, Hilscher MB, Broda CR, Drenth JPH, et al Issues in multi-organ transplantation of the liver with kidney or heart in
polycystic liver-kidney disease or congenital heart disease: Current practices
and immunological aspects.
J Hepatol. 2023;78:1157-1168. PubMedAbstract available
KASAHARA M, Hong JC, Dhawan A Evaluation of living donors for hereditary liver disease (siblings,
heterozygotes).
J Hepatol. 2023;78:1147-1156. PubMedAbstract available
May 2023
EDEN J, Sousa Da Silva R, Cortes-Cerisuelo M, Croome K, et al Utilization of livers donated after circulatory death for transplantation - An
international comparison.
J Hepatol. 2023;78:1007-1016. PubMedAbstract available
April 2023
GUO Z, Zhao Q, Jia Z, Huang C, et al A randomized-controlled trial of ischemia-free liver transplantation for
end-stage liver disease.
J Hepatol. 2023 Apr 20:S0168-8278(23)00233-7. doi: 10.1016/j.jhep.2023. PubMedAbstract available
SCHLEGEL A, Mueller M, Muller X, Eden J, et al A multicenter randomized-controlled trial of hypothermic oxygenated perfusion
(HOPE) for human liver grafts before transplantation.
J Hepatol. 2023;78:783-793. PubMedAbstract available
March 2023
MOOSBURNER S, Sauer IM, Weiss B, Pratschke J, et al How many liver transplantations could be recovered after implementation of
donation after cardiac death in Germany?
J Hepatol. 2023 Mar 11:S0168-8278(23)00176-9. doi: 10.1016/j.jhep.2023. PubMed
GE J, Kim WR, Lai JC, Kwong AJ, et al Response to: "Towards optimally replacing the current version of MELD".
J Hepatol. 2023;78:e100-e101. PubMed
KARTOUN U Towards optimally replacing the current version of MELD.
J Hepatol. 2023;78:e98-e99. PubMed